申请人:Daiso Co., Ltd.
公开号:US05780650A1
公开(公告)日:1998-07-14
A novel process for preparing a 1,4 benzodioxane derivative shown by the formula (1) which is a useful intermediate of circulatory drugs and drugs for psychoneurosis, characterized in sulfonating a phenoxypropanediol with a sulfonyl halide, eliminating the protective group, and then cyclizing the sulfonated compound by treating with a base followed by, if necessary, further sulfonation. ##STR1## In the above formula, R.sup.1 is H, RSO.sub.2, R is alkyl, phenyl which may be substituted with alkyl, R.sup.2, R.sup.3, R.sup.4 are H, halogen, OH, nitro, cyano, formyl, COOH, alkoxycarbonyloxy, alkyl, alkoxy, haloalkyl, N,N-dialkylamino, alkylcarbonyl, alkoxycarbonyl, phenyl which may be substituted by alkyl, etc.22
一种用于制备1,4-苯二氧杂环丙烷衍生物的新工艺,其化学式如下(1),该衍生物是循环药物和精神神经病药物的有用中间体,其特点在于用磺酰卤化物对苯氧基丙二醇进行磺化,去除保护基,然后通过碱处理使磺化化合物环化,如有必要,进一步进行磺化。在上述化学式中,R.sup.1为H,RSO.sub.2,R为烷基,苯基,可能被烷基取代,R.sup.2,R.sup.3,R.sup.4为H,卤素,羟基,硝基,氰基,甲酰基,羧基,烷氧羰氧基,烷基,烷氧基,卤代烷基,N,N-二烷基氨基,烷基羰基,烷氧羰基,苯基,可能被烷基取代等。